R560S: A class II CFTR mutation that is not rescued by current modulators

This publication has 34 references indexed in Scilit:

• Progress in therapies for cystic fibrosis
  The Lancet Respiratory Medicine, 2016
• Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
  New England Journal of Medicine, 2015
• Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis
  EBioMedicine, 2015
• Cystic fibrosis genetics: from molecular understanding to clinical application
  Nature Reviews Genetics, 2014
• Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
  Nature Genetics, 2013
• Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
  Proceedings of the National Academy of Sciences, 2009
• Cystic fibrosis: A worldwide analysis ofCFTR mutations?correlation with incidence data and application to screening
  Human Mutation, 2002
• Two buffer PAGE system-based SSCP/HD analysis: a general protocol for rapid and sensitive mutation screening in cystic fibrosis and any other human genetic disease
  European Journal of Human Genetics, 1999
• Structure and Function of the CFTR Chloride Channel
  Physiological Reviews, 1999
• Detection of five novel mutations of the cystic fibrosis transmembrane regulator (CFTR) gene in Pakistani patients with cystic fibrosis: Y569D, Q98X, 296+12(T>C), 1161delC and 621+2(T>C)
  Human Mutation, 1998